Mauna Kea Technologies SA (EPA:ALMKT)
0.1774
+0.0028 (1.60%)
May 11, 2026, 5:35 PM CET
Mauna Kea Technologies Earnings Call Transcripts
Fiscal Year 2025
-
2025 saw accelerated sales growth, a major debt reduction, and a return to net profitability, with strong U.S. and international momentum. The company is on track for EBITDA profitability by 2027 and continues to expand its MedTech platform and commercial reach.
-
A major debt restructuring and planned capital increase position the company for renewed growth, with strong US sales momentum and profitability targeted for 2027. Commercial expansion and new market entries are expected to drive further value.